Neurologic Manifestations  >>  carbidopa/levodopa  >>  Phase 3
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
carbidopa/levodopa / Generic mfg.
ATS17, NCT01190813: Levodopa for the Treatment of Residual Amblyopia

Completed
3
139
US
Levodopa/Carbidopa, Placebo, Patching
Jaeb Center for Health Research, National Eye Institute (NEI)
Amblyopia
01/14
04/14
NCT01429077: Augmenting Language Therapy for Aphasia: Levodopa

Completed
2/3
36
US
levodopa/carbidopa, Sinemet, Placebo comparator
Shirley Ryan AbilityLab, U.S. Department of Education
Nonfluent Aphasia, Stroke
03/12
03/12

Download Options